Laursen M L
J Cancer Res Clin Oncol. 1980;96(3):231-41. doi: 10.1007/BF00408096.
The present study suggests that pretreatment of mice with cyclophosphamide (CPA) not only suppresses the intestinal immune response to malignant ascites cells but alters the character of the response. Non-treated animals were sensitized by intestinal immunization while CPA-treated animals showed enhanced tumour growth. Sera from enhanced mice contained factors which at the tumor cell membrane were able to interfere with the binding of antibodies detectable by immunofluorescence technique. These factors might be immunoglobins with similarities to IgG, but bound to antigen they were undetectable by the fluorescence method. Enhanced mice were found to be immunologically hyporesponsive to the challenging tumor graft as evidenced by a delay in the immune response to the graft.
本研究表明,用环磷酰胺(CPA)对小鼠进行预处理不仅会抑制肠道对恶性腹水细胞的免疫反应,还会改变反应的性质。未处理的动物通过肠道免疫致敏,而经CPA处理的动物肿瘤生长增强。生长增强小鼠的血清中含有一些因子,这些因子在肿瘤细胞膜上能够干扰通过免疫荧光技术检测到的抗体的结合。这些因子可能是与IgG相似的免疫球蛋白,但与抗原结合后,用荧光法无法检测到。发现生长增强的小鼠对挑战性肿瘤移植物免疫反应低下,这表现为对移植物的免疫反应延迟。